DS17701585 (Compound 11) 是一种选择性的、具有口服活性的EP300和CBP抑制剂，对 CBP、EP300、H3K27和SOX2的IC50值分别为 0.040、0.15、0.45 和 0.70 μM。DS17701585 可用于癌症的研究。

DS17701585 (Compound 11) is a highly selective, orally active EP300 and CBP inhibitor with IC 50 values of 0.040, 0.15, 0.45 and 0.70 μM against CBP, EP300, H3K27 and SOX2. DS17701585 can be used for cancer research [1].

C24H26N4O5S

482.55

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years